Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Naokazu Nagata is active.

Publication


Featured researches published by Naokazu Nagata.


Bone | 1996

Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures

Miyuki Nishikawa; Takuhiko Akatsu; Yasuyuki Katayama; Yoshirou Yasutomo; Seijiro Kado; Nobuo Kugai; Michiko Yamamoto; Naokazu Nagata

We examined the mode of action of bisphosphonates on osteoclastic cell recruitment using mouse marrow cultures with or without osteoblastic cells. Tartrate-resistant acid phosphatase-positive multinucleated cells [TRAP(+)MNC] formed in cultures were determined to be osteoclastic cells. In marrow cultures, TRAP(+) MNC formation in the presence of 10(-8) mol/L 1,25(OH)2D3 was not affected by the addition of 10(-6) mol/L dihydrogen (cycloheptylamino)-methylenebisphosphonate monohydrate (YM175). However, it was inhibited in cocultures of marrow cells with osteoblastic cells. The inhibitory effect was evident throughout the entire culture period. YM175 dose dependently inhibited TRAP(+) MNC formation, and other bisphosphonates--pamidronate and alendronate--also inhibited TRAP(+) MNC formation in the coculture. Similar observations were also made in the coculture of spleen cells with osteoblastic cells. The conditioned media of osteoblastic cells treated with 10(-6) mol/L YM175 inhibited TRAP(+) MNC formation in marrow cultures. The presence of YM175 in methylcellulose cultures affected neither the colony formation of monocyte-macrophage lineage, nor TRAP(+) MNC formation in the succeeding cocultures of recovered cells with osteoblastic cells. These results indicate that YM175 and probably other bisphosphonates as well preferentially inhibit the later stage of osteoclastogenesis through its action on osteoblastic cells. Our findings suggest that part of the inhibitory action by osteoblastic cells in the presence of bisphosphonates is mediated through soluble factor(s).


Acta Diabetologica | 1999

Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus.

S. Kado; Terumasa Nagase; Naokazu Nagata

Abstract We evaluated the relationship between plasma fibrinogen concentration and the serum levels of interleukin-6 (IL-6), its soluble receptor, and their complex in patients with type 2 diabetes mellitus. The study comprised 57 patients with type 2 diabetes and 15 normal healthy controls. Serum levels of IL-6, soluble IL-6 receptor (IL-6R), and circulating IL-6/IL-6R complex were determined by enzyme-linked immunosorbent assays. Correlations between the different study parameters and serum IL-6, IL-6R, or IL-6/IL-6R complex levels were determined by multiple linear regression analysis. Any association between the different study parameters and the serum levels of IL-6, IL-6R, or IL-6/IL-6R complex were determined by stepwise linear regression analysis. The serum IL-6 level in diabetic subjects was significantly higher than in normal healthy controls (3.48 ± 3.29 pg/ml vs 0.784 ± 0.90 pg/ml, mean ± SD, respectively, P = 0.0001). The specific optical density of the serum IL-6/IL-6R complex in diabetic patients was also significantly higher than in normal healthy controls, although there was no significant difference in the serum IL-6R level between diabetic patients and controls. The serum IL-6 concentration was correlated significantly with the HbA1C level (β = 0.58, P = 0.04) by multiple regression analysis. Stepwise regression analysis revealed that the levels of serum IL-6 (F = 8.251), HbA1C (F = 1.08), and serum urea nitrogen (F = 5.603) were associated with the plasma fibrino gen concentration. These results suggest that hyperglycaemia and increased levels of serum IL-6 can increase the plasma fibrinogen concentration, one of the known risk factors for atherosclerosis in patients with type 2 diabetes mellitus.


Clinical and Experimental Pharmacology and Physiology | 1997

EFFECTS OF ENDURANCE TRAINING ON SUPEROXIDE DISMUTASE ACTIVITY, CONTENT AND mRNA EXPRESSION IN RAT MUSCLE#

Shuji Oh-ishi; Takako Kizaki; Junichi Nagasawa; Tetsuya Izawa; Takao Komabayashi; Naokazu Nagata; Keiichiro Suzuki; Naoyuki Taniguchi; Hideki Ohno

1. The purpose of the present study was to investigate the changes in superoxide dismutase (SOD) isoenzyme (Mn2+‐SOD and Cu2+, Zn2+‐SOD) activities, contents and mRNA expressions in rat skeletal muscle during endurance training and a single bout of exercise.


Bone | 1998

Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy.

Takuhiko Akatsu; Takehiko Murakami; Katsuhiro Ono; Miyuki Nishikawa; E. Tsuda; S.-I. Mochizuki; N. Fujise; K. Higashio; Kazuo Motoyoshi; Michiko Yamamoto; Naokazu Nagata

Osteoclastogenesis inhibitory factor (OCIF) is a novel secreted protein that inhibits osteoclastogenesis both in vitro and in vivo. In this study, we examined the effects of OCIF on serum calcium (Ca) concentrations in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. In normal mice, a single intraperitoneal injection of OCIF reduced serum Ca levels in a dose-dependent manner. Significant decrease in serum Ca (by 1.6 +/- 0.3 mg/dL, n = 5) was observed 2 h after the injection of OCIF at 20 mg/kg and the hypocalcemic effect continued for up to 12 h. Serum phosphate (Pi) concentrations also decreased in response to OCIF. Urinary excretion of Ca, Pi, and creatinine did not change significantly after injection of OCIF or vehicle. In hypercalcemic, tumor-bearing nude mice, a single intraperitoneal injection of OCIF at 20 mg/kg resulted in a dramatic decrease in serum Ca (maximal decrease 2.8 +/- 0.37 mg/dL, n = 11), which continued for up to 24 h. The results suggest that OCIF decreased serum Ca through its inhibitory effect on bone resorption. Furthermore, it is suggested that OCIF has therapeutic potential for the treatment of hypercalcemic conditions such as malignancy-associated hypercalcemia.


British Journal of Haematology | 1996

An aggressive nasal lymphoma accompanied by high levels of soluble fas ligand

Ken Sato; Fumihiko Kimura; Yukitsugu Nakamura; Hideaki Murakami; Masayoshi Yoshida; Masato Tanaka; Shigekazu Nagata; Yasuhiro Kanatani; Naoki Wakimoto; Naokazu Nagata; Kazuo Motoyoshi

Fas ligand (FasL), either in the membrane bound form or soluble form, has cytotoxic activity against Fas‐expressing cells. We report a case of nasal lymphoma accompanied by liver damage and pancytopenia. The serum level of soluble FasL (sFasL) was very high on admission, but rapidly decreased to normal levels after chemotherapy for lymphoma. Liver damage and pancytopenia also improved with the decrease in serum sFasL. Since Fas is expressed on both hepatocytes and haemopoietic cells, these facts suggest that FasL was expressed on lymphoma cells and directly associated with pathogenesis of liver damage and pancytopenia through its cytotoxic activity.


Life Sciences | 2001

Expression of intercellular adhesion molecule-1 induced by high glucose concentrations in human aortic endothelial cells

Seijiro Kado; Toru Wakatsuki; Mikio Yamamoto; Naokazu Nagata

We examined the effects of high glucose concentrations on the expression of adhesion molecules in human aortic endothelial cells. Expression levels of both mRNA and protein of intercellular adhesion molecule-1 (ICAM-1) were increased after incubation of endothelial cells with 30 mM glucose for 24 h. The effect of glucose on ICAM-1 was concentration dependent, partially attributable to osmolarity, and enhanced by glycated-collagen. Staurosporine (10 nM), epalrestat (10 microM) suppressed the expression of ICAM-1 mRNA and protein induced by high glucose to variable extents. Aminoguanidine (50 mM) suppressed the expression of ICAM-1 protein. It is thought that soluble ICAM-1 protein is produced by shedding in human aortic endothelial cells because RNA for the soluble form of ICAM-1 formed by variant splicing has not been detected. These results show that glucose is an important determinant of ICAM-1 expression in endothelial cells, and suggest that ICAM-1 molecules induced by hyperglycemia may contribute to the development of atherosclerosis in diabetes mellitus.


Mechanisms of Ageing and Development | 1995

Alterations of superoxide dismutase iso-enzyme activity, content, and mRNA expression with aging in rat skeletal muscle.

Shuji Oh-ishi; Takako Kizaki; Hitoshi Yamashita; Naokazu Nagata; Keiichiro Suzuki; Naoyuki Taniguchi; Hideki Ohno

The alterations of superoxide dismutase iso-enzyme (Cu,Zn-SOD and Mn-SOD) activities, contents, and mRNA expressions with aging were studied in rat soleus muscle (SO) and extensor digitorum longus muscle (EDL). The activity and content of Cu,Zn-SOD in both muscles were significantly higher in old rats (24 months old) than in young rats (4 months old), whereas those of Mn-SOD showed no difference between young and old rats. After normalization to citrate synthase (CS) activity, however Mn-SOD/CS ratio in SO also showed the age-related increase. Moreover, the activities of other major antioxidant enzymes, glutathione peroxidase (GPX) and catalase (CAT), indicated age-related increases only in SO. As for the expressions of mRNAs for SOD iso-enzymes, that of Cu,Zn-SOD in either muscle showed no significant change with aging, unlike its activity and content, although that of Mn-SOD was decreased with aging only in EDL. Thus, aging appeared to raise the level of antioxidant enzyme system in rat skeletal muscle. However, the resistance of Cu,Zn-SOD and Mn-SOD to oxidative stress accompanied by aging was different, the former being obviously greater than the latter. Such changes also differed in muscle fiber type suggesting that fast-twitch fibers are more susceptible to age-related oxidative stress than slow-twitch fibers.


Diabetes Research and Clinical Practice | 1999

Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus

Seijiro Kado; Naokazu Nagata

Serum levels of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in patients with type 2 diabetes mellitus (n = 64) and control subjects (n = 40) were studied. Serum ICAM-1 concentrations in diabetic patients were significantly higher than those of control subjects (378.2 +/- 70.0 versus 220.4 +/- 31.8 ng/ml, P < 0.01). By multiple regression analysis, hemoglobin A1c was independently associated with serum ICAM-1 concentration in patients with diabetes. The serum VCAM-1 concentration of diabetic patients with macroangiopathy was higher than those of patients without macroangiopathy and of control subjects (806.9 + 276.5 versus 639.0 +/- 146.0 (P < 0.01), and 652.1 +/- 146.9 ng/ml (P < 0.01), respectively). There was no difference in serum E-selectin concentration between diabetic patients with or without macroangiopathy and normal control subjects. These results suggest that adhesion molecules may contribute to the development of atherosclerosis in the diabetic state.


Endocrinology | 1998

HYPOCALCEMIC EFFECT OF OSTEOCLASTOGENESIS INHIBITORY FACTOR/OSTEOPROTEGERIN IN THE THYROPARATHYROIDECTOMIZED RAT

Michiko Yamamoto; Takehiko Murakami; Miyuki Nishikawa; Eisuke Tsuda; Shinichi Mochizuki; Kanji Higashio; Takuhiko Akatsu; Kazuo Motoyoshi; Naokazu Nagata

Osteoclastogenesis inhibitory factor (OCIF), also termed as osteoprotegerin (OPG), is a soluble member of the tumor necrosis factor receptor family. Although OCIF/OPG is shown to inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo, its effect on serum calcium level remains to be determined. In this study we examined the acute effect of OCIF on thyroparathyroidectomized rats whose serum calcium concentrations were raised either by exogenous PTH or 1,25-(OH)2D3. When OCIF was administered at the start of PTH infusion, it attenuated the initial rise in serum calcium. When OCIF was administered into rats with established hypercalcemia, it decreased serum calcium rapidly (within 2 hr) and dramatically. OCIF did not increase urinary calcium excretion. These findings, especially the rapid onset of its hypocalcemic effect, suggest that OCIF not only inhibits the formation of osteoclasts but also affects the function and/or survival of mature osteoclasts at doses used in this study.


International Journal of Cancer | 1996

Decreased expression of nucleoside diphosphate kinase α isoform, an nm23-H2 gene homolog, is associated with metastatic potential of rat mammary-adenocarcinoma cells

Mitsugu Fukuda; Akio Ishii; Yoshiro Yasutomo; Nobuko Shimada; Naoshi Ishikawa; Nobuo Hanai; Naokazu Nagata; Tatsuro Irimura; Garth L. Nicolson; Narimichi Kimura

The nm23 gene [encoding nucleoside diphosphate kinase (NDPK)] may act as a metastasis suppressor in certain tumor cells. We investigated the role of NDPK isoforms (α and β) in the metastatic processes, using rat mammary‐adenocarcinoma cell lines of poor (MTC) and high (MTLn3) spontaneous metastatic potential respectively. In these cell lines, as in most rat tissues, the α isoform (nm23‐H2 homolog) was more highly expressed than the β isoform (nm23‐H1 homolog) at the mRNA and protein levels. When examined by Northern‐ and Western‐blot analyses, expression of the 2 isoforms was reduced in highly metastatic MTLn3 cells compared with poorly metastatic MTC cells. The reduced expression was also associated with diminished NDPK‐enzyme activity in the cell extracts. Southern‐blot and RT‐PCR‐SSCP analyses suggested that the 2 genes were not grossly altered or mutated in their translation regions. MTLn3 cell clones transfected with NDPKα or NDPKβ cDNA were all tumorigenic when implanted into the mammary fat pad of syngeneic rats. Among those, only clones transfected with the NDPKα gene exhibited reduced lung metastasis in a spontaneous metastasis assay.

Collaboration


Dive into the Naokazu Nagata's collaboration.

Top Co-Authors

Avatar

Nobuo Kugai

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Kazuo Motoyoshi

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Takuhiko Akatsu

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Hideo Kobayashi

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Michiko Yamamoto

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Osamu Takatani

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Seiki Wada

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Shuji Oh-ishi

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar

Yasuhide Uwabe

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Yasuyuki Katayama

National Defense Medical College

View shared research outputs
Researchain Logo
Decentralizing Knowledge